The broad cellular actions of RNase III family enzymes include ribosomal RNA (rRNA) processing, mRNA decay, and the generation of noncoding microRNAs in both prokaryotes and eukaryotes. Here we report that YmdB, an evolutionarily conserved 18.8-kDa protein of Escherichia coli of previously unknown function, is a regulator of RNase III cleavages. We show that YmdB functions by interacting with a site in the RNase III catalytic region, that expression of YmdB is transcriptionally activated by both cold-shock stress and the entry of cells into stationary phase, and that this activation requires the -factor-encoding gene, rpoS. We discovered that down-regulation of RNase III activity occurs during both stresses and is dependent on YmdB production during cold shock; in contrast, stationary-phase regulation was unperturbed in ymdB-null mutant bacteria, indicating the existence of additional, YmdB-independent, factors that dynamically regulate RNase III actions during normal cell growth. Our results reveal the previously unsuspected role of ribonuclease-binding proteins in the regulation of RNase III activity.
RNase III family ribonucleases, which cleave dsRNA to yield 5Ј phosphate and 3Ј hydroxyl termini, are remarkable for both the extent of their evolutionary conservation in prokaryotic and eukaryotic cells and the diversity of their biological roles (Court 1993; Nicholson 2003; Drider and Condon 2004; MacRae and Doudna 2007) . Containing 226 amino acids, the 25.6-kDa peptide encoded by the rnc gene of Escherichia coli (EC 3.1.26. 3) is structurally the least complex and functionally perhaps the most extensively studied RNase III family member. Rnc monomers, which include an N-terminal catalytic domain and a C-terminal dsRNA-binding domain (dsRBD) (Nashimoto and Uchida 1985) , dimerize to form the enzymatically active protein (Dunn 1982; Nicholson 2003) .
E. coli RNase III was first identified by its ability to catalyze cleavage of ribosomal RNA (rRNA) precursors during ribosome biogenesis (for review, see Dunn 1982) . Subsequently, this enzyme has been shown to mediate the maturation and/or degradation of a variety of transcripts, including tRNA precursors (Régnier and Grunberg-Manago 1989) , conditionally expressed small nonprotein-coding RNAs (Murchison and Hannon 2004) , and mRNAs that encode the exoribonuclease PNPase (Pnp) (Régnier and Portier 1986) , Rnc itself (Matsunaga et al. 1996a,b) , or phage and plasmid proteins (Nicholson 1996 (Nicholson , 2003 . However, notwithstanding the multiplicity and breadth of functions of RNase III, rnc-null mutant E. coli cells are viable and show no phenotypic abnormalities except for a slightly impeded rate of growth (Babitzke et al. 1993 ) and minimally defective translation of certain mRNAs (Talkad et al. 1978) .
The first suggestion that the ribonucleolytic actions of RNase III may be regulated came from the observation by Makarov and Apirion in 1992 that extracts of E. coli cells contain an ∼17-kDa protein that can inhibit in vitro RNase III-dependent processing of p10Sa RNA (Makarov and Apirion 1992 )-a 10Sa RNA precursor (also known as ssrA RNA and tmRNA) that has an important role in the recycling of ribosomes from defective mRNAs (Richards et al. 2008) . However, the nature of this RNase IIIinhibiting moiety and its possible biological role(s) has remained obscure for almost two decades. Using a function-based screen to identify genes encoding proteins that regulate endonucleolytic cleavages by RNase III in vivo, we discovered a highly conserved bacterial protein YmdB that inhibits RNase III actions by binding to the region required for dimerization/activation of the enzyme. We show that production of YmdB and the consequent inhibition of RNase III function are modulated in response to cellular and environmental stresses. Our results reveal a novel mechanism for the dynamic regulation of ribonuclease activity by alterations in cell physiology.
Results

Screening of RNase III regulators in E. coli
To identify trans-acting regulators of RNase III activity, we introduced a library of plasmid-borne E. coli genes [the ASKA library, which includes all known E. coli ORFs expressed from an IPTG-inducible promoter (Kitagawa et al. 2005) , into an E. coli strain (RS7305) containing a single copy of a rncЈ-ЈlacZ reporter gene fusion (Matsunaga et al. 1996a)] . Earlier work has shown that RNase III cleaves its own transcript, and consequently that ␤-galactosidase production from this fusion construct is increased approximately ninefold in cells containing a missense mutation that decreases RNase III activity (Matsunaga et al. 1996a,b) . We reasoned that cleavage of the rncЈ-ЈlacZ transcript would also be affected by down-regulators of Rnc activity encoded by ASKA library ORFs. Regulation of expression of ␤-galactosidase from the rncЈ-ЈlacZ fusion was monitored colorimetrically on MacConkey-Lac and S-gal plates as described in the Materials and Methods. Two colonies that showed reproducibly increased color intensity on culture plates containing IPTG were obtained and the phenotype was confirmed. Sequence analysis of ASKA inserts in plasmids isolated from these colonies identified ymdB (b1045), which is located at the 23.82-min position of the E. coli chromosome and encodes a putative 177-aminoacid 18.88-kDa protein of previously unknown function (Swiss-Prot P0A8D6). Swiss-Prot database analysis of the putative YmdB protein indicates that amino acids 1-175 comprise a macro (A1pp) domain characteristic of Appr-1Љ-p processing family proteins, which catalyze the conversion of ADP-ribose-1Љ-monophosphate (Appr-1Љ-p) to ADP-ribose in eukaryotes (Culver et al. 1994) .
Effect of YmdB on cleavage of RNase III targeted transcripts
Addition of IPTG to cultures of bacteria expressing the ASKA library-derived plasmid-borne ymdB insert under control of the plac promoter increased production of a protein migrating in polyacrylamide gels at the position expected for YmdB (Fig. 1A, left) . This increase was associated with reduced cleavage of transcripts containing RNase III targeted sites in rnc and pnp mRNAs fused to lacZ (Matsunaga et al. 1996a; Beran and Simons 2001) as evaluated quantitatively by measuring ␤-galactosidase activity encoded by lacZ (Fig. 1A, middle) . Using purified RNase III and YmdB to quantify the cellular levels of these proteins in vivo by Western blotting, we determined that the ratio of YmdB to RNase III that resulted in ∼90% inhibition of RNase III activity was 4:1 (Fig. 1A, right) . IPTG-induced production of YmdB in vivo also resulted in the accumulation of 30S rRNA (Fig. 1B) -which is known to increase in bacteria deficient in RNase III activity (Babitzke et al. 1993) . That these effects result specifically from inhibition of Rnc activity was confirmed using P L -putL-lac fusion transcripts, which are attacked at a site immediately 3Ј of putL to generate an 80-nucleotide (nt) product (Sloan et al. 2007) ; turn on of the YmdB expression led to accumulation of the 140-nt unprocessed transcript and concurrent reduction of the 80-nt RNase III cleavage product (Fig. 1C) .
Inhibition of RNase III cleavages by purified His-tagged YmdB protein was demonstrated biochemically in vitro and the inhibition was shown to be dependent quantitatively on YmdB using R1.1 RNA (60 nt in size), a small RNase III substrate containing a sequence that is the site of RNase III-mediated processing of the phage T7 polycistronic early mRNA precursor ( Fig. 1D ; Amarasinghe et al. 2001) . The distinctly different YmdB/RNase III ratios found to affect RNase III activity in vivo and in vitro imply that experimental conditions employed for the in vitro assays do not entirely mimic the physiological state.
YmdB interaction with RNase III
Notwithstanding the ability of YmdB to inhibit RNase III-mediated cleavage of R1.1 RNA, gel shift analysis failed to detect binding of YmdB to this substrate. Instead, multiple lines of evidence indicated that YmdB interacts with the RNase III protein. This interaction was suggested initially by our detection of an RNase IIIsized ∼26 kDa protein, using rabbit polyclonal antibody generated against E. coli RNase III, in histidine-tagged YmdB preparations purified by Ni 2+ column chromatography from rnc + -but not from rnc mutant-bacteria (data not shown). More direct evidence of the ability of YmdB and RNase III to interact was obtained in experiments showing that biotin-tagged YmdB preparations purified by a streptavidin bead-binding procedure (see Materials and Methods) also included an RNase III-size protein detected on Western blots by RNase III antibody ( Fig. 2A) . The observed copurification of this protein with biotin-tagged YmdB was unaffected by treatment of YmdB with ribonuclease A (+ vs. −), implying that interaction of this protein with RNase III does not require an RNA intermediate. Independently of these results, highthroughput MALDI-TOF screening (Butland et al. 2005) of protein complexes isolated from E. coli cells has identified YmdB in protein complexes containing RNase III (A. Emili, pers. comm.) .
Physical interaction between YmdB and RNase III in vivo was further confirmed and the RNase III segment required for the interaction was identified by analysis, in cells mutated in the chromosomal rnc gene, of truncated RNase III proteins expressed from the pKSC1-Rnc plasmids and captured by YmdB attached to streptavidincoated beads (Fig. 2B, top) . The results of these experiments indicated that amino acids 1-148 of RNase III are sufficient for its binding to YmdB, and also that amino acids 120-140 are necessary for such binding (Fig. 2B,  bottom) . The required region overlaps a domain that has been reported, in the RNase III proteins of Aquifex aeolicus, Thermotoga maritima, and Mycobacterium tu-berculosis, to be essential for enzymatic activity (Akey and Berger 2005; Gan et al. 2006) . Analogous immunoblot experiments using full-length biotin-tagged YmdB and truncated YmdB derivatives showed interaction of RNase III with the full-length YmdB protein, but not with any of the truncated YmdB proteins tested (Supple- mental Fig. S1A,B) . Moreover, none of the truncated YmdB derivatives we tested regulated the activity of RNase III in vivo, as measured by the colorimetric assays described above (data not shown), implying that sequences located along most or all of the length of the YmdB protein are required for its function as an RNase III regulator. Interestingly, the macro-like domain of YmdB is congruent with virtually the full-length YmdB protein (Supplemental Fig. S1C ).
Full catalytic activity of RNase III requires dimerization of the protein (Dunn 1982; Nicholson 2003; Meng and Nicholson 2008) . We used the cross-linking agent DSS (Disuccinimidyl suberate; Pierce) (Li and Nicholson 1996) to experimentally test the notion that YmdB binding may interfere with RNase III dimerization. As shown in Figure 2C , RNase III bands migrating at the positions expected for RNase III monomers and dimers were observed in cross-linked reactions analyzed by SDS-PAGE (Fig. 2C, lanes 4,6) , but in the absence of cross-linker, only a band migrating in the monomer position was detected (Fig. 2C, lanes 1,3) . Addition of YmdB at the concentration tested (5 µM) resulted in a 33% reduction of the RNase III dimer band relative to monomer (Fig. 2C , lane 4 vs. lane 6) as shown by optical scanning of Coomassie blue stained gels and the appearance of a band that we found by MALDI-TOF analysis contains both RNase III and YmdB (Fig. 2C, lane 6) . Reactions containing both the cross-linker and YmdB, but not reactions containing YmdB alone, showed a band migrating as an YmdB dimer, and the intensity of this band was decreased by 50% in the presence of 5 µM RNase III (Fig.  2C , lane 5 vs. lane 6). These results, which further confirm the ability of YmdB to interact with RNase III, strongly suggest that YmdB, as well as RNase III, exists in a dimeric form, and that interaction between the two proteins diminishes the ability of each to form homodimers.
We anticipated that the YmdB-RNase III interaction might be inhibiting RNase III activity by decreasing the ability of the endoribonuclease to interact with substrates. However, a test of the effects of YmdB on RNase III binding to R1.1 RNA in vitro showed surprisingly that the interaction increased RNase III binding to this substrate (Fig. 2E ). This observation parallels the similar paradoxical finding that point mutations affecting amino acid residue 117, which is in the vicinity of the RNase III region we showed here to be required for its interaction with YmdB, enhanced the RNA-binding ability of RNase III, while rendering the enzyme catalytically inactive . Taken together, these results raise the prospect that the monomeric form of RNase III, while being inactive catalytically (Dunn 1982; Nicholson 2003) , may bind more tightly to substrates than RNase III dimers. Interestingly, neither the catalysisnullifying effects of point mutations in RNase III amino acid 117 nor of YmdB was detectable in reactions containing Mg 2+ ; our unpublished data), and consequently, the cation used in both the mutational studies and our YmdB investigations was Mn 2+ .
Effect of cell growth and cold shock on YmdB gene expression
Our examination of primary microarray data obtained during studies that globally tested the effects of various physiological and environmental perturbations on E. coli mRNA abundance suggested that expression of the ymdB gene may be affected by cell physiology (Gutiér-rez-Rios et al. 2003; Traxler et al. 2006; White-Ziegler et al. 2008) . To further investigate this possibility, to quantify any cell growth-related changes in expression of ymdB, and to identify sites involved in the regulation of ymdB mRNA production, we made transcriptional fusions between ymdB and lacZ and inserted these into the E. coli chromosome as single-copy reporter gene constructs. Regions containing putative promoters in an operon postulated to contain the ymdA and ymdC genes (Karp et al. 2007) , as well as ymdB, were identified using BPROM (Softberry, Inc.)-which detects consensus sequences for RNA polymerase 70 recognition sites (Campbell et al. 2002) . We observed that fusion to lacZ of a region containing 230 nt 5Ј to the postulated ymdB protein start codon (Fig. 3) activated ␤-galactosidase production from the reporter gene. Moreover, lacZ expression from this construct began to increase in samples taken from bacteria in early stationary phase, and 2 h later reached a steady-state level approximately eightfold higher than was observed in logarithmically growing cells (Fig. 4A, top panels) . Consistent with these findings, Western blot analysis showed that the intensity of a protein band that reacted with anti-YmdB rabbit polyclonal antibody (Fig. 4A, bottom) and that was not detected in ymdB mutant bacteria was ∼10-fold greater in stationary versus log-phase cells. An analogous increase in the abundance of the ymdB transcript during stationary phase was observed by microarray analysis (Gutiérrez-Rios et al. 2003) . The observed increase in both ymdB mRNA and protein observed during stationary phase was dramatically reduced in rpoS mutant bacteria, which lack the stationary-phase -factor RpoS ( Fig. 4A ; Klauck et al. 2007 ), indicating its dependence on the production of RpoS. Consistent with this finding, ymdB was among the multiple genes showing altered mRNA abundance in rpoS mutant bacteria during microarray studies of global gene expression (Traxler et al. 2006) . Also in agreement with earlier microarray results, which showed elevated abundance of ymdB mRNA during growth of E. coli cells at low temperature (White-Ziegler et al. 2008) , we observed that shift of cultures to 13°C resulted in an approximately threefold increase in ymdB transcription, as quantified by ␤-galactosidase production from the 
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ymdB-lacZ fusion construct, and YmdB protein by Western blotting (Fig. 4B) .
YmdB-mediated effects of stress on RNase III activity
We hypothesized that inhibition of RNase III function by the observed elevation of YmdB production during stationary phase would lead to reduced cleavage of RNase III targeted transcripts encoded by a chromosomally inserted pnpЈ-ЈlacZ fusion transcript and a consequent stationary-phase elevation of ␤-galactosidase encoded by the fusion construct. As shown in Figure 5A , such an increase was observed. However, the increase was not sustained throughout the period of stationary-phase elevation of YmdB (Fig. 5A,B) and, importantly, also occurred in ymdB mutant bacteria-indicating its independence of YmdB. Similarly, no difference in the steady state level of the RNase III protein, which cleaves the transcripts that encode it (Matsunaga et al. 1996a (Matsunaga et al. ,b, 1997 , was detected during stationary-phase growth of ymdB + versus ymdB mutant bacteria-notwithstanding the elevation of YmdB protein observed in these bacteria during stationary-phase cells (Fig. 5B) . We conclude from these results that RNase III activity undergoes downregulation during the stationary phase and that such down-regulation does not require the action of YmdB.
We observed that RNase III activity was decreased also during cold shock, as indicated by increased production of ␤-galactosidase activity encoded by a rncЈ-ЈlacZ fusion gene inserted into the E. coli chromosome. However, in contrast to the YmdB independence of stationary-phase effects on RNase III activity, down-regulation of RNase III activity during cold shock was reduced in ymdB mutant bacteria (Fig. 5C) , demonstrating a role for ymdB in the regulation of RNase III during cold stress. While YmdB abundance was approximately threefold higher during stationary phase versus cold stress, the ␤-galactosidase activity encoded by the rncЈ-ЈlacZ fusion was approximately the same under both conditions (Figs. 4, 5) , implying that the inverse relationship between YmdB and RNase III is not linear.
Discussion
While it has long been known that the cellular actions of ribonucleases are affected by physiological conditions (Nilsson et al. 1984; Georgellis et al. 1993; Chen and Deutscher 2005; Freire et al. 2006) , there has been limited understanding of the mechanisms that underlie ribonuclease regulation. Proteins that alter ribonuclease activity by interacting with substrates have been identified, and in the case of some RNase III family members, was monitored by measuring turbidity (OD 600 ) using spectrophotometer (Beckman-DU70). To measure the relative ratio of YmdB protein, total cellular proteins (OD 600 = 0.2) extracted from KSC002, KSC003, and Keio-ymdB (ymdB − ) cells at specific time points (indicated by arrows in the top right panel) were separated by Criterion 12% Bis-Tris gel with XT-MES buffer, immunoblotted using antiYmdB and anti-S1, and quantified (bottom). ND indicates that band was not detected in the Western blotting. (B) ymdB transcription in cold stress. Briefly, cells were grown to OD 600 ∼0.3 at 37°C, shifted to 13°C and continuously grown at 13°C, 250 rpm. The turbidity was almost unchanged (data not shown). (Top) Filled squares and empty circles represent the increase of ␤-gal (␤-galactosidase) activity (%) by cold stress from strains containing chromosomal fusion of either promoterless-lacZ (KSC001) or ymdB-lacZ (KSC002). The value was determined by dividing the ␤-galactosidase activity at each time point by that of −10 min before the stress. (Bottom) YmdB and S1 proteins were immunoblotted from total cellular proteins(OD 600 = 0.2) using antibodies of each protein and the ratio of YmdB protein during the time of cold stress was determined. Values shown are the relative intensities of YmdB to the value at −10 min of cold stress. viral proteins have been shown to regulate RNA-mediated gene silencing by competing with the enzyme's ability to bind to targets (Chao et al. 2005) . Our discovery of an E. coli protein that regulates RNase III activity by interacting directly with this ribonuclease reveals a previously unsuspected mechanism for dynamic control of RNase III actions. The effects of YmdB extend beyond E. coli RNase III, as this E. coli protein inhibited the cleavages by the RNase III (AbsB protein) (Price et al. 1999; Xu et al. 2008 ) of the unrelated bacterial species, Streptomyces coelicolor (Supplemental Fig. S2C ). YmdB homologs are present in multiple bacterial species and the actions of such YmdB homologs are likely to be specific for RNase III family members, as no inhibition of endoribonucleases RNases E or G was observed on the E. coli YmdB protein (data not shown). Conversely, recently described enzyme-binding inhibitors of E. coli RNase E (Lee et al. 2003; Gao et al. 2006; Zhao et al. 2006) did not detectably affect the actions of RNase III (our unpublished data). While the observed effect of YmdB also modulated PNPase expression (Fig. 5A) , this effect was shown to be dependent entirely on YmdB inhibition of RNase III (Supplemental Fig. S3 ), which cleaves PNPase transcripts. YmdB was isolated using rncЈ-ЈlacZ chromosomal fusion developed previously by Simons and colleagues (Matsunaga et al. 1996a (Matsunaga et al. ,b, 1997 to study mutations in the rnc gene. We adapted this fusion for detection of trans-acting gene products that increased the expression of ␤-galactosidase encoded by a chromosomally inserted rncЈ-ЈlacZ fusion construct. As the rnc segment of the rncЈ-ЈlacZ transcript is cleaved by RNase III, down-regulation of RNase III resulted in elevation of ␤-galactosidase expression. The ASKA library of plasmid-borne ORFs that we screened expresses individual gene products at high levels under control of a lac promoter inducible by IPTG (Kitagawa et al. 2005) .
The ability of YmdB to down-regulate RNase III activity has been shown by us both in vivo and in vitro. In our in vitro experiments (Fig. 1D) , we observed that RNase III treatment of 5Ј-[ 32 P]-R1.1 RNA, a well-characterized substrate shown in previous experiments to be cleaved at a single site within the descending arm of a hairpin structure (Amarasinghe et al. 2001) , yielded a doublet band (the "M" band) when purified YmdB was added. YmdB alone showed no effect on the substrate. A similar band suggestive of a secondary cleavage site at nucleotide position U 45 was observed also following treatment of R1.1 RNA by a mutant RNase III enzyme (the E65 mutation, Zhang et al. 2004) . We speculate that both the E65 mutation and YmdB binding to RNase III may perturb the cleavage specificity of the endoribonuclease, leading to the targeting of R1.1 RNA at secondary cleavage site.
Our studies showed that RNase III segments in Nterminal catalytic regions containing amino acids 120-140 are necessary and amino acids 1-148 are sufficient for YmdB binding. It has been known that RNase III functions as a homodimer and contains two dsRBDs and two catalytic sites (Dunn 1982; Nicholson 2003) . It also has been reported that the N-terminal portion of bacterial RNase III polypeptides includes the NucD (catalytic domain), which self-associates to form a single "processing center" at the subunit interface that contains the catalytic sites (Zhang et al. 2004) . We found that like RNase III, YmdB can also form homodimers, and that interaction between these two proteins decreased homodimer formation of each. We suggest that RNase IIIYmdB heterodimer formation may disrupt formation of the RNase III processing center. However, while YmdB can clearly inhibit the endoribonucleolytic activity of RNase III, interaction of the functionally inhibited RNase III with the RNA substrate was observed to be increased. Such uncoupling of binding and catalytic activity is reminiscent of the effects of mutations at amino acid residue 117, which also increased binding to R1.1 RNA while rendering the RNase III protein catalytically inactive .
Inhibition of RNase III activity by YmdB was observed in vitro when Mn 2+ was the cation cofactor, but not when Mg 2+ was the cation. Interestingly, the RNase III E117 mutation identified by Sun and Nicholson (2001) was also found to abrogate endoribonuclease activity in vitro when tested using Mn . Position 117, which Sun and Nicholson (2001) included in a region they designated as the "inhibitory" site of the enzyme, is also within the RNase III segment we showed to be sufficient for binding to YmdB. Collectively, these findings raise the possibility that Mn 2+ binding at or near position 117 enables YmdB interaction with RNase III, and consequent inhibition of enzymatic activity.
We hypothesize that the formation of YmdB/RNase III heterodimers may inhibit RNase III activity by interfering with the formation of RNase III homodimers, which is believed to be the active form of the enzyme (Meng and Nicholson 2008) . Production of YmdB was increased during stationary phase and cold shock, and our data indicate that this increase is mediated at the transcriptional level. Moreover, increased ymdB transcription during stationary phase was dependent on the stationary-phase factor RpoS encoded by the rpoS gene. Conversely, overexpression of YmdB during log-phase growth activated production of RpoS protein (our unpublished data), consistent with evidence that RpoS is elevated in E. coli cells mutated in RNase III, which has been shown to cleave the rpoS mRNA leader (Resch et al. 2008 ). As we showed that YmdB is an inhibitor of RNase III, these findings suggest an autoregulatory relationship between the ymdB and rpoS gene products.
We also screened genomic DNA libraries we constructed to express E. coli genes under control of their natural promoters. In these screenings, five additional trans-acting regulators of ␤-galactosidase expression from the rncЈ-ЈlacZ fusion construct were identified (our unpublished data), suggesting that RNase III activity is controlled by other trans-acting gene products in addition to YmdB. Our experimental results (Fig. 5) showing that RNase III can be down-regulated during stationary phase by an YmdB-independent mechanism is consistent with this notion. Moreover, the actions of some of the putative regulators we identified in our screen were observed to be affected by the composition of the media on which cells were assayed-raising the further prospect that regulation by these agents is modulated by cell growth conditions. Additional experimentation is being carried out to elucidate whether cellular regulation of RNase III activity in E. coli is, in fact, controlled by a battery of trans-acting regulators that collectively mediate a dynamic response to physiological and environmental factors.
The effects of YmdB on RNase III activity in vivo also raise the question of how such an inhibitor can affect an autoregulated system as the autoregulation might be expected to compensate for the inhibitor's actions. Similarly, how can a missense mutation increase RNase III abundance, as has been reported previously (Matsunaga et al. 1997; Wilson et al. 2002) , instead of simply leading to compensation that maintains the enzyme activity at a "normal level"? Analogous findings, both for mutations and inhibitors, have been reported for another autoregulated ribonuclease, RNase E (Jain and Belasco 1995; Sousa et al. 2001; Ow et al. 2002; Lee et al. 2003) suggesting that the autoregulation of both ribonucleases is imperfect.
As observed for RNase III itself, ymdB-like genes are widely distributed in nature, and GenBank analysis by us has revealed ymdB homologs in both eukaryotes and prokaryotes. However, the structure of the operon containing YmdB (i.e., ymdA-ymdB-ymdC) is highly conserved in only Salmonella and Shigella-both close relatives of E. coli (Karp et al. 2007 ). As noted earlier, the YmdB protein (Swiss-Prot P0A8D6) includes a macro (A1pp) domain, a module of ∼180 amino acids that can bind ADP-ribose, an NAD metabolite or related ligands (Schreiber et al. 2006) . The macro domain motif is present in both multidomain proteins and simpler proteinswhere it appears to be the primary structural component (Amé et al. 2004) . Given the inhibition by YmdB of endoribonucleolytic cleavages by a Streptomyces coelicolor homolog of E. coli RNase III (AbsB) (Price et al. 1999) , it is worth noting that S. coelicolor encodes a 169 amino acid "stand alone" macro domain homolog of YmdB (i.e., SC6450).
Materials and methods
Medium, bacterial strains, plasmids, and phage vectors
All bacterial strains, plasmids, and phages used during this study listed in Supplemental Table S1 . Bacterial strains were routinely grown in Luria-Bertani (LB) medium (Sambrook and Russell 2001) . The concentrations (per milliliter) of antibiotics used were 100 µg of ampicillin (Ap 
Library screening
The ASKA library (Kitagawa et al. 2005 ) was transformed into RS7305 (Matsunaga et al. 1996a ) and colonies (∼20,000) were separately plated onto either LB/S-Gal (50 µg/mL; Sigma-Aldrich) with 0.1 mM IPTG or MacConkey-Lac plate. After overnight incubation of the plate at 37°C, dark-black or deep-red colonies were picked. The plasmid DNAs were obtained from each colony and transformed with fresh RS7305 cells. Screenings were repeated and positive colonies were selected. As the final step, each colony was streaked onto both LB/S-Gal with 0.1 mM IPTG and MacConkey-Lac plate. Plasmid DNAs from colonies showing positive results on both plates were prepared and sequenced.
Construction of chromosomal lacZ fusions
We PCR-amplified a DNA fragment containing regions of ymdA operon-from 1104,813 to 1105,042 of E. coli K12 genome (GenBank U00096)-and cloned a fragment to lacZ transcriptional fusion vector, pSP417 (Podkovyrov and Larson 1995) , generating a plasmid pKSC2 (ymdB-lacZ). The lacZ fusions in pSP417 (negative control) and pKSC2 were transferred onto the chromosome using the transducing phage system (Simons et al. 1987) . The ymdB-lacZ fusion from pKSC2 was transferred into RS45, whereas the control pSP417 was transferred into RS74 via a double recombination event. We also used either RS741 (pnpЈ-ЈlacZ) or RS473 (rncЈ-ЈlacZ) from RS8872 (Beran and Simons 2001) or RS7305 (Matsunaga et al. 1996a ) lysogen, respectively, to transfer fusion into BW25113 strain. Plaques containing the recombinant phages were isolated based on their blue plaque phenotype. The recombinant phages were used to lysogenize BW25113, Keio-rpoS, or KeioymdB and generated the following strains: KSC001 (BW25113; KSC1) with a chromosomal promoterless lacZ gene; KSC002 (BW25113; KSC2), KSC004 (Keio-rpoS; KSC2); KSC005 (BW25113; RS741), KSC006 (Keio-ymdB; RS468), and KSC007 (Keio-ymdB; RS468). Single lysogens are verified by PCR-based method (Powell et al. 1994 ).
Measurement of ␤-galactosidase activity
␤-Galactosidase activity in whole cells was determined as described by Miller (1992) . Values represent the means of at least three independent experiments.
RNA extraction and Northern blotting
In general, total RNAs were extracted using the hot phenol method as described previously (Sambrook and Russell 2001) , followed by RNeasy kit cleanup (Qiagen). For 30S RNA precursor detection, 5 µg of total RNA isolated from wild-type cells of uninduced or induced YmdB protein were run on 1.5% nondenaturing agarose gel containing ethidium bromide (0.5 µg/mL) and visualized by AlphaImager (AlphaInnotech). For Northern blot analyses, 15 µg of total RNAs were fractionated on a 10% polyacrylamide gel containing 7 M Urea, electrotransferred onto Hybond-N + membrane (AP Biotech), and cross-linked the membrane using UV-cross-linker at 1250 J/cm 2 (Stratagene). Primer putL (5Ј-CGTTCATCCTGAACCCGCCGCGC-3Ј; early part of the HK022 pL transcript; Sloan et al. 2007 ) was radiolabeled using [␥-32 P]ATP and T4 Polynucleotide Kinase (New England Biolabs) and used as a probe to detect put-L-mRNA in the total RNA pool. Hybridization, washing of the membranes, and detection of signals were carried out according the RapidHyb buffer (Promega) protocol.
Protein purifications
His-tagged RNase III was purified and dialyzed from BL21(DE3) rnc105 containing pET15b-rnc as described (Amarasinghe et al. 2001) and His-tagged YmdB was purified from E. coli SDF205 (rnc105 mutant) cells having ASKA-YmdB as follows: The cultures were grown to mid-log phase, induced with 0.5 mM IPTG for 3 h and harvested. The cells were resuspended in buffer A [20 mM Tris-HCl at pH 8.0, 0.5 M NaCl, 10 mM imidazole] containing lysozyme (5 mg/mL), DNase I (10 mg/mL), Complete EDTA-free Protease Inhibitor Cocktail Tablets (Roche Molecular Biochemicals)]. After cell disruption by passing through French Press, the cell suspension was centrifuged at 30,000g, 30 min, and the crude extract was obtained. The crude extract was loaded onto Ni 2+ column packed with 5 mL of Ni-Sepharose 6 fast flow resin (GE Healthcare) and equilibrated with buffer A. Unbound proteins are washed with 100 mL of 20 mM imidazole in buffer A and the protein was eluted with 15 mL of elution buffers containing 20, 50, 100, 200, or 400 mM imidazole in buffer A, respectively, with the gravity flow rate of 0.2 mL/min. YmdB protein was eluted from 50 mM imidazole fraction. Pools eluted from at 200 mM imidazole buffer were concentrated using Centriplus-YM10 (Millipore) and dialyzed against buffer B (30 mM Tris-HCl at pH 8.0, 50 mM NaCl, 1 mM EDTA, 1 mM DTT). The YmdB protein concentration was determined by Bradford assay kit (Bio-Rad) and purity was identified by SDS-PAGE gel with Coomassie blue staining. The absence of RNase III was determined by Western blotting using antibodies to RNase III.
In vitro cleavage assays
Generally, RNase III cleavage assays were performed according to a protocol (Amarasinghe et al. 2001) , using 5Ј-[ 32 P] R1.1 RNA in the cleavage buffer (10 mM Tris-HCl at pH 7.5, 12 mM NH 4 Cl, 0.1 mM EDTA, 0.1 mM DTT, 0.25 mg/mL yeast tRNA) containing 20 U of rRNasin (Promega). Specific features of the assays are detailed in the appropriate figure. Reactions were initiated by adding Mn 2+ at final concentration of 0.4 mM to the protein/RNA mixtures. All reactions were carried out for 10 min at 37°C. Reactions were quenched by adding same volume of 2× loading dye that contained 20 mM EDTA (Amarasinghe et al. 2001) . Aliquots were electrophoresed in 10% polyacrylamide gel containing 7 M Urea and 1× TBE buffer. The results were visualized by phosphorimaging (Typhoon Trio) and quantified by ImageQuant software. Reactions were performed in at least three independent experiments and representative data are reported.
Gel shift assays
Gel mobility-shift assays were carried out as described in previous publications (Li and Nicholson 1996; Amarasinghe et al. 2001; Sun and Nicholson 2001; Meng and Nicholson 2008) , using [␣-32 P] UTP-labeled R1.1 RNA and proteins that were preincubated on ice for 10 min at 37°C in Ca 2+ (10 mM) buffer. Electrophoresis was carried out at 4°C in a 6% (w/v) polyacrylamide gel (Acrylamide:Bisacrylamide, 80:1) containing 0.5× TBE buffer and 10 mM CaCl 2 . Binding reactions were visualized by phosphorimaging and quantified using ImageQuant software.
Immunodetection of YmdB, RNase III, and S1 proteins
Polyclonal YmdB antibodies were obtained from rabbits inoculated with YmdB peptide (NЈ-CYDEE NAHLY ERLLT QQGDE) from Proteintech Group, Inc., and were affinity-purified. RNase III antibodies raised from rabbits were obtained from Drs. R.W. Simon and K. Lee as a gift. We used S1 antibodies (Feng et al. 2001) to provide an internal standard to evaluate the amount of cell extracts in different lanes. Cellular proteins were detected by separating proteins on Criterion XT Bis-Tris gels with appropriate percentage and buffer, followed by immunoblot by antibodies of interesting proteins, anti-rabbit-IgG:HRP conjugate (Promega) and ECL detection reagents (Millipore). Specific proteins were imaged by VersaDoc 1000 (Bio-Rad) and quantified by Quantity One (Bio-Rad).
Detection of protein interactions in vivo
Full-length YmdB was cloned into XhoI and BamHI site of pDW363 vector (Tsao et al. 1996) . Then, E. coli XL1 blue cells were transformed with pDW363 or pDW363-YmdB, and the resulting cells were cultured in LB media containing 8 µg/mL of D-biotin (Sigma-Aldrich) at 37°C. Expression of biotin-tagged YmdB was initiated by 1 mM of IPTG when the culture OD 600 reached ∼0.4 and induced for 3 h. Cells were harvested by centrifugation at 5000 rpm for 10 min and resuspended in 1/5 volume of ice-cold NP-40 lysis buffer (150 mM sodium chloride, 1.0% NP-40, 50 mM Tris at pH 8.0). The cell lysate was obtained after passing the cells through French press (2000 psi) two times, and followed by centrifugation for 15 min at 4°C to remove intact cells and cell debris. The protein concentration was determined by BCA method (BCA Protein Assay Kit, Pierce). Aliquots (5 mg of protein) were further treated with RNase A (at a final concentration of 5 mg/mL) at 37°C for 15 min. Aliquots with or without treatment with RNase A were mixed with each 100 µL of streptavidin-agarose slurry (Invitrogen) and the volume was adjusted to 800 µL. Following 1 h rotation at 4°C, resins were centrifuged at 6000 rpm for 5 min and then washed extensively 10 times with ice-cold NP-40 buffer. Finally, the streptavidin agarose resins were resuspended with 100 µL of 2× SDS protein loading buffer (100 mM Tris-Cl at pH 6.8, 4% SDS, 200 mM ␤-mercaptoethanol) and boiled for 10 min. The released proteins were electrophoresed on 12% Criterion Bis-Tris gel with XT-MES buffer (Bio-Rad) and the presence of RNase III was analyzed by Western blotting using anti-RNase III.
Identification of RNase III region for YmdB interaction
Specific regions of the RNase III molecules were cloned into NcoI and HindIII site of plasmid pKSC1. E. coli NB478 (W3110, rnc <> cat) cells were transformed with both pKSC1-RNase III deletion constructs (amino acids 1-120, 1-140, 1-155, and 140-226 of Rnc) and pDW363-YmdB. Cells were cultured in LB media containing 8 µg/mL of D-biotin at 37°C. Proteins were induced by adding both 0.1% L-arabinose and 1 mM IPTG to exponentially grown cells, followed by further growth for 2 h Coprecipitation analyses were done as described in Detection of Protein Interactions in Vivo. The presence of RNase III was detected by Western blotting using RNase III antibody.
Protein cross-linking and mass mapping
To monitor the change of dimerization status of RNase III and YmdB, we used a cross-linking reaction that has been described for E. coli RNase III (Li and Nicholson 1996) using DSS, an amine cross-linking agent. Briefly, cross-linking reactions (20-µL volumes) including RNase III (5 µM monomer) and/or YmdB (5 µM monomer) were carried out for 15 min at room temperature in 10 mM MOPS (pH 7.5), containing 250 mM NaCl, 0.1 mM EDTA, and 0.1 mM DTT. Reactions were quenched by boiling after adding 20 µL of 2× SDS-gel loading buffer supplemented with 0.5 M Tris base, then analyzed by electrophoresis in 12% Criterion XT Bis-Tris gel with XT-MOPS buffer (BioRad), and visualized by Coomassie blue staining. The presence of RNase III and YmdB from heterodimer band was confirmed by mass mapping analysis (PAN Facility, Stanford University). The intensity of bands on the gel was quantified by optical scanning of Coomassie stained gel, followed by analysis using the ImageQuant program.
